Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus”

559 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 559 results

Not applicableStudy completedNCT01077271
What this trial is testing

Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA

Who this might be right for
Premature Infants
Abbott 124
Early research (Phase 1)Study completedNCT05987072
What this trial is testing

Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.

Who this might be right for
Respiratory Syncytial Virus Infection
Pfizer 12
Not applicableStudy completedNCT05727202
What this trial is testing

Project STARFISH - PRJ0002679

Who this might be right for
SARS-CoV-2 InfectionInfluenza AInfluenza Type B+1 more
Thermo Fisher Scientific, Inc 1,909
Post-approval studies (Phase 4)Active Not RecruitingNCT07185399
What this trial is testing

Systems Biological Analysis of Immune Responses to RSV Vaccine

Who this might be right for
Respiratory Syncytial Virus (RSV)
Emory University 14
Not applicableStudy completedNCT01915394
What this trial is testing

Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)

Who this might be right for
Respiratory Syncytial Virus InfectionsInfections, Epidemics
Ankara University 250
Early research (Phase 1)Active Not RecruitingNCT07289503
What this trial is testing

Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above

Who this might be right for
Respiratory Syncytial Virus
Suzhou Abogen Biosciences Co., Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT03379675
What this trial is testing

Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 72
Testing effectiveness (Phase 2)Study completedNCT02873286
What this trial is testing

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic 420
Not applicableLooking for participantsNCT06998251
What this trial is testing

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)

Who this might be right for
Pneumococcal InfectionsRespiratory Syncytial Virus (RSV) InfectionInfluenza Infection
University Hospital, Geneva 280
Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Early research (Phase 1)Study completedNCT01906164
What this trial is testing

Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 101
Not applicableStudy completedNCT02786381
What this trial is testing

Idylla IFV-RSV Panel Clinical Testing

Who this might be right for
Respiratory Tract InfectionsInfluenza, HumanRespiratory Syncytial Virus Infections
Janssen Pharmaceutica N.V., Belgium 213
Early research (Phase 1)Active Not RecruitingNCT06216093
What this trial is testing

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)
EuBiologics Co.,Ltd 100
Testing effectiveness (Phase 2)Study completedNCT04196101
What this trial is testing

Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects

Who this might be right for
Respiratory Syncytial Virus
Enanta Pharmaceuticals, Inc 82
Early research (Phase 1)Study completedNCT05281263
What this trial is testing

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc. 30
Early research (Phase 1)Study completedNCT01459198
What this trial is testing

Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT03403348
What this trial is testing

A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants

Who this might be right for
Healthy
Janssen BioPharma, Inc. 130
Early research (Phase 1)Study completedNCT02115815
What this trial is testing

Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
MedImmune LLC 246
Early research (Phase 1)Looking for participantsNCT07516418
What this trial is testing

Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

Who this might be right for
Respiratory Syncytial Virus (RSV)Influenza A(H5N1)
Sanofi 570
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Next Page